* On June 9, co initiated a voluntary field removal of four lots of its 3D revascularization devices - SEC filing
* Voluntary field removal was based on company’s identification of an issue involving a raw material component of the devices
* Penumbra Inc - does not currently expect that this voluntary action will have material impact on its previously issued revenue guidance - sec filing
